Histotripsy Ablation of Bone Tumors: Feasibility Study in Excised Canine Osteosarcoma Tumors.
Histotripsy Ablation of Bone Tumors: Feasibility Study in Excised Canine Osteosarcoma Tumors.
复制标题
DOI:
10.1016/j.ultrasmedbio.2021.08.004
复制
发表时间:
2021-12
影响因子:
2.9
通讯作者:
Vlaisavljevich E
中科院分区:
文献类型:
--
作者:
Arnold L;Hendricks-Wenger A;Coutermarsh-Ott S;Gannon J;Hay AN;Dervisis N;Klahn S;Allen IC;Tuohy J;Vlaisavljevich E
Osteosarcoma (OS) is a primary bone tumor affecting both dogs and humans. Histotripsy is a non-thermal, non-invasive focused ultrasound method using controlled acoustic cavitation to mechanically disintegrate tissue. In this study, we investigate the feasibility of treating primary OS tumors with histotripsy using a 500 kHz transducer on excised canine OS samples harvested after surgery at the Veterinary Teaching Hospital at Virginia Tech. Samples were embedded in gelatin tissue phantoms and treated with the 500 kHz histotripsy system using 1–2 cycle pulses at a pulse repetition frequency of 250 Hz and a dosage of 4,000 pulses/point. Separate experiments also tested histotripsy effects on normal canine bone and nerve using the same pulsing parameters. After treatment, histopathological evaluation of the samples was completed. To demonstrate the feasibility of treating OS through intact skin/soft tissue, additional histotripsy experiments tested OS with overlying tissues. Generation of bubble clouds was achieved at the focus in all tumor samples at peak negative pressures of 26.2 ± 4.5 MPa. Histopathology showed effective cell ablation in treated areas for OS tumors, with no evidence of cell death or tissue damage in normal tissues. Treatment through tissue/skin resulted in generation of well-confined bubble clouds and ablation zones inside OS tumors. Results demonstrate the feasibility of treating OS tumors with histotripsy.
登录
查看更多内容
DOI:
10.1109/tuffc.2014.2947
发表时间:
2014-04-01
影响因子:
3.6
作者:
Kim, Yohan;Hall, Timothy L.;Cain, Charles A.
通讯作者:
Cain, Charles A.
影响因子:
3.8
作者:
Jones, R. L.;McCall, J.;Judson, I. R.
通讯作者:
Judson, I. R.
影响因子:
3.5
作者:
Kim, Y.;Vlaisavljevich, E.;Xu, Z.
通讯作者:
Xu, Z.
DOI:
10.1097/01.rvi.0000092666.72261.6b
发表时间:
2003-10-01
影响因子:
2.9
作者:
Lu, DSK;Raman, SS;Sayre, J
通讯作者:
Sayre, J
DOI:
10.1186/s13046-020-01685-w
发表时间:
2020-09-04
期刊:
Journal of experimental & clinical cancer research : CR
影响因子:
--
作者:
Cui J;Dean D;Hornicek FJ;Chen Z;Duan Z
通讯作者:
Duan Z